Inventor
Sylvia Braselmann
Inventor
San Francisco, CA, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides18%
C12NMicroorganisms or enzymes18%
A61KPreparations for medical, dental or toiletry purposes9%
C07DHeterocyclic compounds9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests9%
PatentTitleYear
9,353,112'Synthesis of polycyclic alkaloids'20168,927,564'Synthesis of polycyclic alkaloids'20156,762,284'Nucleotide sequences that encode phosphatidylinositol-3 kinase associated proteins and uses thereof'20046,133,419'Nucleotide sequences that encode phosphatidylinositol-3\' kinase associated proteins and uses thereof'20006,017,763'G-beta-gamma regulated phosphatidylinositol-3\' kinase'20005,856,132'G-beta-gamma regulated phosphatidylinositol-3\' kinase'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999Patents assigned to ONYX PHARMACEUTICALS (1)· patent assignee history
1999–2016Based in San Francisco, CA, US· patent location history
2000–2004Patents assigned to ONYX PHARMA INC (3)· patent assignee history
2000Patents assigned to BABRAHAM INST (1)· patent assignee history
2015–2016Patents assigned to RIGEL PHARMACEUTICALS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ONYX PHARMA INC | 3 | 2000–2004 |
| RIGEL PHARMACEUTICALS INC | 2 | 2015–2016 |
| BABRAHAM INST | 1 | 2000 |
| ONYX PHARMACEUTICALS | 1 | 1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 6 | 1999–2016 |